# HEMAGO Monitoring and Impact on the Occurrence of Complications During Pregnancy in Sickle Cell Patients

> **NCT06620887** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 100 (actual)

## Conditions studied

- Sickle Cell Disease and Pregnancy

## Interventions

- **OTHER:** Evaluate the impact of HEMAGO program on maternal morbidity and mortality in sickle cell disease patients during their pregnancies.

## Key facts

- **NCT ID:** NCT06620887
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-01
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-04-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620887, "HEMAGO Monitoring and Impact on the Occurrence of Complications During Pregnancy in Sickle Cell Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06620887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*